Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion
Joseph R. Leventhal(Northwestern Memorial Hospital), Suzanne T. Ildstad(University of Louisville), Christopher Houston(Angelo State University), Nedjema Sustento‐Reodica(Northwestern University), Michaël Abécassis(University of Arizona), David J. Tollerud(National Cancer Institute), Larry D. Bozulic(Talaris Therapeutics (United States)), Lorenzo Gallon(University of Illinois Chicago), Joshua Miller(Northwestern Memorial Hospital), Mary Jane Elliott(University of Louisville)
Cited by 153
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
|Liver Transplantation|2010|1.2k